Why the study?
Does the addition of 18F-FDG-PET/CT and/or CTA change the final diagnosis in patients with suspected TAVI-IE?
Does the addition of 18F-FDG-PET/CT and/or CTA change the final diagnosis in patients with suspected TAVI-IE?
The addition of 18F-FDG-PET/CT and/or CTA is a valuable diagnostic tool that changes the final diagnosis in a third of patients with suspected TAVI-IE.
May support adjunctive imaging in suspected TAVI-IE; leaves open prospective validation of management impact.
Addition of ¹⁸F-FDG-PET/CT and/or CTA changed the final diagnosis in 33% of patients and proved to be a valuable diagnostic tool in patients with suspected TAVI-IE.
No takes yet. Share an insight, caveat, or question.
Wahadat et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: